190 related articles for article (PubMed ID: 22650160)
1. Identification of novel subgroup A variants with enhanced receptor binding and replicative capacity in primary isolates of anaemogenic strains of feline leukaemia virus.
Stewart H; Adema KW; McMonagle EL; Hosie MJ; Willett BJ
Retrovirology; 2012 May; 9():48. PubMed ID: 22650160
[TBL] [Abstract][Full Text] [Related]
2. Identification of a feline leukemia virus variant that can use THTR1, FLVCR1, and FLVCR2 for infection.
Shalev Z; Duffy SP; Adema KW; Prasad R; Hussain N; Willett BJ; Tailor CS
J Virol; 2009 Jul; 83(13):6706-16. PubMed ID: 19369334
[TBL] [Abstract][Full Text] [Related]
3. Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant.
Miyake A; Kawasaki J; Ngo H; Makundi I; Muto Y; Khan AH; Smith DJ; Nishigaki K
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996094
[TBL] [Abstract][Full Text] [Related]
4. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes.
Rigby MA; Rojko JL; Stewart MA; Kociba GJ; Cheney CM; Rezanka LJ; Mathes LE; Hartke JR; Jarrett O; Neil JC
J Gen Virol; 1992 Nov; 73 ( Pt 11)():2839-47. PubMed ID: 1331290
[TBL] [Abstract][Full Text] [Related]
5. Distinctive receptor binding properties of the surface glycoprotein of a natural feline leukemia virus isolate with unusual disease spectrum.
Bolin LL; Chandhasin C; Lobelle-Rich PA; Albritton LM; Levy LS
Retrovirology; 2011 May; 8():35. PubMed ID: 21569491
[TBL] [Abstract][Full Text] [Related]
6. Disruption of thiamine uptake and growth of cells by feline leukemia virus subgroup A.
Mendoza R; Miller AD; Overbaugh J
J Virol; 2013 Mar; 87(5):2412-9. PubMed ID: 23269813
[TBL] [Abstract][Full Text] [Related]
7. Novel Feline Leukemia Virus Interference Group Based on the env Gene.
Miyake A; Watanabe S; Hiratsuka T; Ito J; Ngo MH; Makundi I; Kawasaki J; Endo Y; Tsujimoto H; Nishigaki K
J Virol; 2016 May; 90(9):4832-4837. PubMed ID: 26889025
[TBL] [Abstract][Full Text] [Related]
8. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
Tailor CS; Kabat D
J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
[TBL] [Abstract][Full Text] [Related]
9. The receptor binding site of feline leukemia virus surface glycoprotein is distinct from the site involved in virus neutralization.
Ramsey IK; Spibey N; Jarrett O
J Virol; 1998 Apr; 72(4):3268-77. PubMed ID: 9525654
[TBL] [Abstract][Full Text] [Related]
10. In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant.
Rohn JL; Moser MS; Gwynn SR; Baldwin DN; Overbaugh J
J Virol; 1998 Apr; 72(4):2686-96. PubMed ID: 9525586
[TBL] [Abstract][Full Text] [Related]
11. Refrex-1, a soluble restriction factor against feline endogenous and exogenous retroviruses.
Ito J; Watanabe S; Hiratsuka T; Kuse K; Odahara Y; Ochi H; Kawamura M; Nishigaki K
J Virol; 2013 Nov; 87(22):12029-40. PubMed ID: 23966402
[TBL] [Abstract][Full Text] [Related]
12. Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses.
Anderson MM; Lauring AS; Robertson S; Dirks C; Overbaugh J
J Virol; 2001 Nov; 75(22):10563-72. PubMed ID: 11602698
[TBL] [Abstract][Full Text] [Related]
13. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
[TBL] [Abstract][Full Text] [Related]
14. Are endogenous feline leukemia viruses really endogenous?
Stewart H; Jarrett O; Hosie MJ; Willett BJ
Vet Immunol Immunopathol; 2011 Oct; 143(3-4):325-31. PubMed ID: 21715022
[TBL] [Abstract][Full Text] [Related]
15. Feline leukemia virus infection requires a post-receptor binding envelope-dependent cellular component.
Hussain N; Thickett KR; Na H; Leung C; Tailor CS
J Virol; 2011 Dec; 85(23):12529-36. PubMed ID: 21917946
[TBL] [Abstract][Full Text] [Related]
16. Interference with superinfection and with cell killing and determination of host range and growth kinetics mediated by feline leukemia virus surface glycoproteins.
Kristal BS; Reinhart TA; Hoover EA; Mullins JI
J Virol; 1993 Jul; 67(7):4142-53. PubMed ID: 8389921
[TBL] [Abstract][Full Text] [Related]
17. Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein.
Brojatsch J; Kristal BS; Viglianti GA; Khiroya R; Hoover EA; Mullins JI
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8457-61. PubMed ID: 1326757
[TBL] [Abstract][Full Text] [Related]
18. Host cell range of T-lymphotropic feline leukemia virus in vitro.
Shojima T; Nakata R; Miyazawa T
Biochem Biophys Res Commun; 2006 Jul; 345(4):1466-70. PubMed ID: 16730653
[TBL] [Abstract][Full Text] [Related]
19. Feline Leukemia Virus (FeLV) Endogenous and Exogenous Recombination Events Result in Multiple FeLV-B Subtypes during Natural Infection.
Erbeck K; Gagne RB; Kraberger S; Chiu ES; Roelke-Parker M; VandeWoude S
J Virol; 2021 Aug; 95(18):e0035321. PubMed ID: 34232703
[TBL] [Abstract][Full Text] [Related]
20. Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses.
Pandey R; Ghosh AK; Kumar DV; Bachman BA; Shibata D; Roy-Burman P
J Virol; 1991 Dec; 65(12):6495-508. PubMed ID: 1658356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
